Companies: 10,795·Total market cap: $144.5T
Phoenix Life Sciences International Limited

Phoenix Life Sciences International Limited

PLSIOTCHealthcare
$0.00
$-0.82(-99.99%)
Market Cap$365910
P/E Ratio
52W High
52W Low
Overview

Phoenix Life Sciences International Limited (PLSI) Revenue

Annual & quarterly revenue history · segment & region breakdown

PLSI · revenue · updated Jun 10, 2026

Core revenue metrics

Phoenix Life Sciences International Limited trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.

TTM revenue
$0.00B
4-quarter sum · USD
YoY growth
+0.00%
vs FY
Price / sales
mktCap ÷ TTM rev
Revenue per day
Est. TTM ÷ 365
Revenue / employee
$0K
5 employees
FY
FY
5Y CAGR
Fiscal year end
Dec 31
Currency
USD · GAAP
Filing
10-K / 10-Q
Source: FMP · Phoenix Life Sciences International Limited SEC filings · GAAPUpdated: 2026-06-10

Revenue trend

· Annual
YoY revenue growth %
revenue trend · revenue chart · revenue by year · revenue history

Revenue history

Fiscal year endRevenueChangeGrowth
PLSI revenue by year · PLSI revenue history · PLSI annual revenue data

About Revenue & Reporting

Revenue (also called sales, net sales, or turnover) is the total income Phoenix Life Sciences International Limited receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.

Phoenix Life Sciences International Limited reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.

Data sourced from Phoenix Life Sciences International Limited's 10-K and 10-Q SEC filings via Financial Modeling Prep.

Figures tie to SEC 10-K/10-Q and FMP income-statement endpoints where noted.

Frequently asked questions

PLSI revenue · 4 questions

PLSI's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.

PLSI revenuePLSI annual revenuewhat is PLSI revenuePLSI TTM revenue

Source: FMP · Phoenix Life Sciences International Limited SEC filings · GAAP · Phoenix Life Sciences International Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026